We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vitamin D Supplements May Provide Inexpensive and Effective Boost Against TB

By Biotechdaily staff writers
Posted on 22 May 2007
Scientists have shown that a single 2.5 mg dose of vitamin D may be enough to trigger the immune system to fight against tuberculosis (TB) and similar bacteria for at least six weeks. More...


These findings came from a study that identified an extremely high incidence of vitamin D deficiency among those communities in London (UK) most at risk from the disease, which kills around two million people each year.

Whereas a diet of oily fish can provide some vitamin D, the main source of the body's vitamin D comes from exposing the skin to sunlight. In Britain, however, the amount of sunlight is usually not enough to generate vitamin D in the skin between October and April, and much of the population becomes deficient during the winter and spring.

Researchers from Queen Mary's School of Medicine and Dentistry (London; UK) and the Wellcome Trust Centre for Research in Clinical Tropical Medicine at Imperial College London (UK) studied patients at Newham University Hospital and Northwick Park Hospital (both in London, UK) who had been exposed to TB. They found that over 90% of such patients had a vitamin D deficiency.

Vitamin D was used to treat TB in the pre-antibiotic era, when special sanatoria were constructed in sunny locations, such as the Swiss Alps. But until now, no study has assessed the effect of vitamin D supplementation on immunity to mycobacteria, the family of bacteria that cause TB.

The researchers performed a randomized control trial on a group of volunteers who were given either a 2.5 mg vitamin D supplement or a placebo. Samples of the volunteers' blood were then tested in Dr. Robert Wilkinson's Wellcome Trust-funded laboratory at Imperial College, to see whether the supplement affected the immune system's ability to resist infection by mycobacteria.

"We found that a single large dose of vitamin D was sufficient to enhance a person's immunity to the bacteria,” stated Dr. Adrian Martineau, from the division of medicine at Imperial College London, who coordinated the study. "This is very significant given the high levels of vitamin D deficiency in people at the highest risk of TB infection, and shows that a simple, cheap supplement could make a significant impact on the health of people most at risk from the disease.”

According to the UK Health Protection Agency, the incidence of TB in the United Kingdom is increasing, with about 8,000 new cases a year. Cases in the United Kingdom are predominantly confined to the major cities and approximately 40% of all cases are in London. TB is also a major global problem: an estimated one-third of the world's population--nearly two billion people--are infected. Nine million people per year develop the active disease worldwide, which kills two million each year.

"Most cases of TB in London arise from people who have already become infected with the bacteria but in whom it lies latent,” noted Prof. Chris Griffiths from Queen Mary's School of Medicine and Dentistry. "Our results indicate that vitamin D supplementation may prevent reactivation of latent TB. Identifying people with latent TB and providing supplements could be an important strategy for tackling the disease.”

The treatment is both very inexpensive and safe. Vitamin D supplements could be prescribed for patients with or at risk of latent TB through GP surgeries. Dr. Martineau pointed out, "Our work adds to the growing evidence that vitamin D may have a wide range of important health benefits, including preventing falls and fractures and reducing risk of cancer and diabetes, as well as boosting the immune system against infection. Population-wide supplementation needs to be considered by public health planners. Milk and orange juice could be fortified with vitamin D, as in the US and Canada. At present, only margarine is supplemented in the UK, and recent studies show that this is not an effective way to prevent vitamin D deficiency.”


Related Links:
Queen Mary's School of Medicine and Dentistry
Imperial College London

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image

Rapid Testing Panel Simultaneously Detects 15 Drugs of Abuse in Urine Within 21 Minutes

Illicit drug use and excessive use of prescription medicine is growing across the US amid a severe opioid crisis. Although overdose fatalities were reported to have declined by nearly 27% in 2024, many... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.